Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice.
Hurez V, Daniel BJ, Sun L, Liu AJ, Ludwig SM, Kious MJ, Thibodeaux SR, Pandeswara S, Murthy K, Livi CB, Wall S, Brumlik MJ, Shin T, Zhang B, Curiel TJ.
Hurez V, et al. Among authors: thibodeaux sr.
Cancer Res. 2012 Apr 15;72(8):2089-99. doi: 10.1158/0008-5472.CAN-11-3019. Epub 2012 Apr 11.
Cancer Res. 2012.
PMID: 22496463
Free PMC article.